Azathioprine Increases the Risk of Non‐Melanoma Skin Cancer Among Organ Transplant Recipients; an Updated Systematic Review and Meta‐Analysis
Our findings indicate that OTRs treated with AZA are at an increased risk for SCC and NMSC. Therefore, it is recommended to prioritize monitoring for skin cancer in OTRs treated with AZA.
Authors
- S. Jamal Omidi (ORCID: https://orcid.org/0009-0002-1516-2865)
- Bahareh Ebrahimi (ORCID: https://orcid.org/0000-0001-8959-8202)
- Salman Khazaei Khazaei
- Amir Mohammad Salehi
- Alireza Sadeghi
- Romina Rezaei
Institutions
- Hamedan University of Medical Sciences (IR)
- Children's Medical Center (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Cancer Reports
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/cnr2.70473
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00